|
GSK drug halves attacks in hard-to-treat asthma
Reuters LONDON (Reuters) – An experimental drug for treating severe asthma from GlaxoSmithKline nearly halved the number of attacks suffered by patients with a hard-to-treat form of the disease in a clinical study, boosting hopes for its commercial success … GlaxoSmithKline Sees Promise in New Drug for Severe Asthma |
View full post on asthma – Google News